<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01011504</url>
  </required_header>
  <id_info>
    <org_study_id>TMC-BIV-08-02</org_study_id>
    <nct_id>NCT01011504</nct_id>
  </id_info>
  <brief_title>Utilisation of Angiox® in European Practice</brief_title>
  <acronym>EURO-vision</acronym>
  <official_title>A Registry Study to Determine Utilisation Patterns in Patients Receiving Angiox®, and Collect Descriptive Safety and Outcome Data to Inform the Risk Management Strategy for Europe.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Medicines Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Medicines Company</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine utilisation patterns in patients receiving
      Angiox® in participating European centres. Additionally, through the collection of
      descriptive safety and outcomes data, this study will contribute to the Risk Management
      strategy for Europe
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Posology and usage patterns of Angiox®: Dose(s) and time of bolus and infusion administered</measure>
    <time_frame>from hospital admission until hospital discharge, or 7 days after administration (which ever is earlier).</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death Myocardial infarction Unplanned revascularisation Stroke Major* and minor bleeding Thrombocytopenia Stent thrombosis Adverse events and serious adverse events</measure>
    <time_frame>measured in-hospital (prior to discharge), and at post-hospital discharge in outpatient as per local practice (30 days)</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">2019</enrollment>
  <condition>Stable Angina (SA)</condition>
  <condition>NSTE-ACS (NSTEMI and UA)</condition>
  <condition>STEMI (STE-ACS)</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Approximately, 2,000 patients will be included at centres throughout Europe
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eligible for, and receive treatment with Angiox®.

          -  Willing and able to provide written informed consent to the use of their data in
             accordance with relevant local Data Protection laws, policies and regulations

        Exclusion Criteria:

          -  Participation in other interventional clinical research studies involving the
             evaluation of investigational drugs, including Angiox®, or devices at the time of
             enrolment.

          -  Patients not eligible for treatment for Angiox®.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Nienaber, Prof.</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_official>
    <last_name>Martial Hamon, Prof</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Caen</name>
      <address>
        <city>Caen</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Klinik I Kardiologie/Pneumologie/Internistische</name>
      <address>
        <city>Rostock</city>
        <zip>D-18057</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2009</study_first_submitted>
  <study_first_submitted_qc>November 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2009</study_first_posted>
  <last_update_submitted>January 18, 2012</last_update_submitted>
  <last_update_submitted_qc>January 18, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 19, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angina, Stable</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

